CivaDerm: a new four-day skin cancer radiation bandage
Official title: CivaDerm Non-Melanoma Skin Cancer Radiation Therapy Device
Funded at Civatech Oncology, INC. · NIH-11408990 · Data updated 2026-11-12
A new four‑day radiation bandage for non-melanoma skin cancer aims to treat facial and other areas without multiple clinic visits or big scars.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Civatech Oncology, INC. NIH-funded |
| Lab location | 1 site (Morrisville, UNITED STATES) |
| Project start | September 17, 2026 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $1,205,017 |
| NIH project number | 1R44CA314878-01 |
| Project ID | NIH-11408990 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with non‑melanoma skin cancer, especially on the face or head, who are candidates for radiation therapy.
✕Less likely to help
Patients with cancers not suitable for topical/platelet-based radiotherapy or who require different treatment modalities may not benefit.
What this research studies
This project develops CivaDerm, a novel radiation bandage that patients wear for four days to deliver therapy directly to the cancer while sparing surrounding healthy tissue. It seeks to shorten treatment time and reduce the need for frequent clinic visits compared with traditional radiotherapy. The approach could minimize skin damage and scarring, helping patients maintain form and function in visible areas like the face. If successful, it could offer a convenient and less painful option for people with non‑melanoma skin cancer.
Why it matters
Potential benefit: If successful, patients could receive effective treatment with fewer clinic visits and less scarring.
How similar studies have gone: Previous work in targeted radiotherapy and bandage-based delivery has shown promise, but clinical results for this exact device are forthcoming.
Where this research is happening
-
Civatech Oncology, INC.
Morrisville, United States Active
Researchers
- Principal investigator: Perez, Kristy — Civatech Oncology, INC.
- Study coordinator: Perez, Kristy
Related research
Other NIH-funded projects on the same topics.
-
MOSAIC II: MAP Wound Matrix to speed graft readiness after non-melanoma skin cancer surgery
A randomized trial tests a moldable wound scaffold (MAP Wound Matrix) to speed healing and time to graft-ready skin after head and neck cancer surgeries in adults.
-
Low-energy skin radiation patches for treating non-melanoma skin cancer
A patient-friendly device idea uses a patch to deliver a tiny amount of radiation right at the skin to treat non-melanoma skin cancer in as few visits.
-
Safer medicines to prevent basal and squamous (non‑melanoma) skin cancer
Researchers are developing new, non‑toxic oral rexinoid medicines aimed at preventing basal cell and squamous cell skin cancers, especially for people with weakened immune systems like organ transplant recipients.
-
Creating safe drugs to prevent non-melanoma skin cancer
This study is working on new medications to help prevent skin cancer in people with weakened immune systems, like those who have had organ transplants, by creating safer and more effective options that don’t have the usual side effects of current treatments.
-
New ways to prevent non-melanoma skin cancer
This study is looking for new ways to help prevent non-melanoma skin cancers, like basal cell and squamous cell carcinoma, by understanding how these cancers develop and testing new treatments that could lower your risk.
-
Advancing Treatments for Melanoma and Skin Cancer
This program is looking for new and better ways to treat melanoma and other skin cancers, especially when current treatments aren't enough.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.